Random Musings From The Clinical Trials Guru
The $7 Billion ‘Abandoned’ Drug: Edward Van Wezel's Story From For Blood and Money Ep. 1044
Dan interviews Edward van Wezel from BioGeneration Ventures (BGV)
Random Musings From The Clinical Trials Guru
Dan interviews Edward van Wezel from BioGeneration Ventures (BGV)